Orchid Pharma [ORCHPHARMA] vs Healthcare Global [HCG] Detailed Stock Comparison

Orchid Pharma Ltd.

NSE
Loading...

Healthcare Global Enterprises Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Orchid Pharma Ltd. wins in 10 metrics, Healthcare Global Enterprises Ltd. wins in 7 metrics, with 0 ties. Orchid Pharma Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Orchid Pharma Ltd. Healthcare Global Enterprises Ltd. Better
P/E Ratio (TTM) 151.55 438.11 Orchid Pharma Ltd.
Price-to-Book Ratio 2.27 8.81 Orchid Pharma Ltd.
Debt-to-Equity Ratio 0.22 177.91 Orchid Pharma Ltd.
PEG Ratio -0.94 -1.86 Orchid Pharma Ltd.
EV/EBITDA 19.08 26.72 Orchid Pharma Ltd.
Profit Margin (TTM) -29.57% 0.77% Healthcare Global Enterprises Ltd.
Operating Margin (TTM) -12.26% 7.73% Healthcare Global Enterprises Ltd.
EBITDA Margin (TTM) N/A 7.73% N/A
Return on Equity 7.86% 4.49% Orchid Pharma Ltd.
Return on Assets (TTM) 5.90% 1.25% Orchid Pharma Ltd.
Free Cash Flow (TTM) $-1.31B $1.08B Healthcare Global Enterprises Ltd.
1-Year Return 28.43% 15.13% Orchid Pharma Ltd.
Price-to-Sales Ratio (TTM) 4.75 3.48 Healthcare Global Enterprises Ltd.
Enterprise Value $30.29B $96.59B Healthcare Global Enterprises Ltd.
EV/Revenue Ratio 3.31 3.90 Orchid Pharma Ltd.
Gross Profit Margin (TTM) 30.94% 49.98% Healthcare Global Enterprises Ltd.
Revenue per Share (TTM) $68 $176 Healthcare Global Enterprises Ltd.
Earnings per Share (Diluted) $3.74 $1.32 Orchid Pharma Ltd.
Beta (Stock Volatility) N/A -0.24 N/A

Orchid Pharma Ltd. vs Healthcare Global Enterprises Ltd. Stock Performance Analysis

Loading Price Chart...

ORCHPHARMA
HCG

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Orchid Pharma Ltd.4.77%14.04%34.84%90.29%16.93%21.14%
Healthcare Global Enterprises Ltd.-0.50%-0.09%-1.55%14.26%-12.66%-3.90%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Orchid Pharma Ltd.28.43%115.84%-34.53%2,272.83%233.07%448.18%
Healthcare Global Enterprises Ltd.15.13%98.83%227.36%250.86%260.08%260.08%

Performance & Financial Health Analysis: Orchid Pharma Ltd. vs Healthcare Global Enterprises Ltd.

MetricORCHPHARMAHCG
Market Information
Market Cap i₹28.76B₹85.12B
Market Cap CategorySmall capMid cap
10 Day Avg. Volume i70,827156,294
90 Day Avg. Volume i94,990214,217
Last Close₹960.85₹627.35
52 Week Range₹480.00 - ₹970.00₹513.30 - ₹804.65
% from 52W High-0.94%-22.03%
All-Time High₹2,654.25 (Apr 05, 2021)₹804.65 (Oct 24, 2025)
% from All-Time High-63.80%-22.03%
Growth Metrics
Quarterly Revenue Growth-0.02%0.13%
Quarterly Earnings Growth-0.05%0.13%
Financial Health
Profit Margin (TTM) i-0.30%0.01%
Operating Margin (TTM) i-0.12%0.08%
Return on Equity (TTM) i0.08%0.04%
Debt to Equity (MRQ) i0.22177.91
Cash & Liquidity
Book Value per Share (MRQ)₹249.86₹65.64
Cash per Share (MRQ)N/A₹14.54
Operating Cash Flow (TTM) i₹-82,697,000₹824.28M
Levered Free Cash Flow (TTM) i₹996.57M₹444.10M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i₹0.00N/A

Valuation & Enterprise Metrics Analysis: Orchid Pharma Ltd. vs Healthcare Global Enterprises Ltd.

MetricORCHPHARMA (Apr 24, 2026)HCG (Apr 23, 2026)
Price Ratios
P/E Ratio (TTM) i151.55438.11
Forward P/E i17.6661.80
PEG Ratio i-0.94-1.86
Price to Sales (TTM) i4.753.48
Price to Book (MRQ) i2.278.81
Market Capitalization
Market Capitalization i₹28.76B₹85.12B
Enterprise Value i₹30.29B₹96.59B
Enterprise Value Metrics
Enterprise to Revenue i3.313.90
Enterprise to EBITDA i19.0826.72
Risk & Other Metrics
Beta iN/A-0.24
Book Value per Share (MRQ) i₹249.86₹65.64

Financial Statements Comparison: Orchid Pharma Ltd. vs Healthcare Global Enterprises Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricORCHPHARMA (2025)HCG (2025)
Revenue/Sales i9.14B22.01B
Cost of Goods Sold i5.64B10.84B
COGS % of Revenue i61.7%49.2%
Gross Profit i3.50B11.17B
Gross Margin i38.3%50.8%
Research & Development i83.67MN/A
Operating Income (EBIT) i971.59M1.87B
Operating Margin i10.6%8.5%
EBITDA i1.59B4.22B
EBITDA Margin i17.4%19.2%
Pre-Tax Income i955.65M569.64M
Pre-Tax Income % of Revenue i10.5%2.6%
Income Tax i-1.94M81.30M
Income Tax % of Revenue i0.0%0.4%
Net Income (Profit) i996.57M488.34M
Profit Margin i10.9%2.2%

Balance Sheet & Liquidity Metrics

MetricORCHPHARMA (2025)HCG (2025)
Cash & Equivalents i211.07M2.36B
Total Current Assets i8.07B8.44B
Total Current Assets % of Revenue i88.3%38.3%
Total Current Liabilities i2.86B10.46B
Total Current Liabilities % of Revenue i31.2%47.5%
Long-Term Debt i1.32B13.80B
Long-Term Debt % of Revenue i14.4%62.7%
Total Shareholders Equity i12.67B9.90B
Retained Earnings i-20.78B-4.09B
Retained Earnings % of Revenue i-227.3%-18.6%
Property, Plant & Equipment i166.44M934.71M

Cash Flow Statement Comparison

MetricORCHPHARMA (2025)HCG (2025)
Operating Cash Flow i-82.70M824.28M
Operating Cash Flow % of Revenue i-0.9%3.7%
Capital Expenditures i-1.50B-2.07B
Free Cash Flow i-1.31B1.08B
FCF Margin i-14.3%4.9%
Debt Repayment iN/A-817.59M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricORCHPHARMAHCG
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i50.72M149.30M
Float Shares i61.70M55.09M
% Held by Insiders i69.84%66.66%
% Held by Institutions i17.43%16.16%
% Held by Public i12.73%17.18%

Dividend Analysis & Yield Comparison: Orchid Pharma Ltd. vs Healthcare Global Enterprises Ltd.

MetricORCHPHARMAHCG
Last 12-Month Dividend i₹0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i₹0.00N/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i₹0.00N/A
Ex-Dividend DateN/AN/A